1. Home
  2. FMC vs GKOS Comparison

FMC vs GKOS Comparison

Compare FMC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMC
  • GKOS
  • Stock Information
  • Founded
  • FMC 1910
  • GKOS 1998
  • Country
  • FMC United States
  • GKOS United States
  • Employees
  • FMC N/A
  • GKOS N/A
  • Industry
  • FMC Major Chemicals
  • GKOS Medical/Dental Instruments
  • Sector
  • FMC Industrials
  • GKOS Health Care
  • Exchange
  • FMC Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • FMC 8.0B
  • GKOS 7.4B
  • IPO Year
  • FMC N/A
  • GKOS 2015
  • Fundamental
  • Price
  • FMC $57.71
  • GKOS $144.14
  • Analyst Decision
  • FMC Hold
  • GKOS Strong Buy
  • Analyst Count
  • FMC 14
  • GKOS 12
  • Target Price
  • FMC $68.00
  • GKOS $135.08
  • AVG Volume (30 Days)
  • FMC 1.3M
  • GKOS 593.0K
  • Earning Date
  • FMC 10-29-2024
  • GKOS 11-04-2024
  • Dividend Yield
  • FMC 4.09%
  • GKOS N/A
  • EPS Growth
  • FMC 195.29
  • GKOS N/A
  • EPS
  • FMC 11.60
  • GKOS N/A
  • Revenue
  • FMC $4,167,899,999.00
  • GKOS $360,347,000.00
  • Revenue This Year
  • FMC N/A
  • GKOS $22.68
  • Revenue Next Year
  • FMC $4.53
  • GKOS $24.98
  • P/E Ratio
  • FMC $4.92
  • GKOS N/A
  • Revenue Growth
  • FMC N/A
  • GKOS 18.70
  • 52 Week Low
  • FMC $50.03
  • GKOS $59.22
  • 52 Week High
  • FMC $68.72
  • GKOS $145.84
  • Technical
  • Relative Strength Index (RSI)
  • FMC 43.80
  • GKOS 58.11
  • Support Level
  • FMC $54.25
  • GKOS $135.74
  • Resistance Level
  • FMC $61.58
  • GKOS $144.99
  • Average True Range (ATR)
  • FMC 1.96
  • GKOS 5.06
  • MACD
  • FMC -0.23
  • GKOS 0.10
  • Stochastic Oscillator
  • FMC 29.74
  • GKOS 82.13

About FMC FMC Corporation

FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Share on Social Networks: